We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

X

SelfDose™ Patient-Controlled Injector

Off-the-Shelf Delivery System

The SelfDose patient-controlled injector is an off-the-shelf delivery system that is ergonomically designed for optimal patient administration. Extensive human factors studies have been performed with the SelfDose injector, confirming the intuitive design, supporting ease of use and patient acceptance, and potentially minimizing the need for costly validation. 

 

The patient-controlled delivery rate of the SelfDose injector may help to minimize pain compared to spring-based auto-injectors. 

Features:

  • Designed for a 1mL long prefilled glass syringe
  • Visual indicator to guide proper drug administration
  • Passive needle safety system that helps prevent needlestick injury
  • Needle depth can be customized to optimize drug absorption

Unique Designs to Meet Your Specific Applications
Every day, West is working by our partners’ side to design and manufacture drug packaging and delivery systems that will bring their drugs from concept to patient efficiently, reliably and safely. West's concept design, development, engineering and project management teams can facilitate all steps necessary to take a product from concept to commercialization, including full validation and chemical and functional testing. Custom components can be provided in ready-to-use or ready-to-sterilize formats.

Click here for a real world example of a custom development project between West and a customer.

SelfDose Self Injector Logo

 

 

SelfDose™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.

SmartDose® is a registered trademark of Medimop Medical Projects, Ltd., a subsidiary of West pharmaceutical Services, Inc. 

West markets SmartDose® as a multi-component system only.  Final assembly of the prefilled component is completed by the pharmaceutical company.